作者:Rosario González-Muñiz、MaJosé Domínguez、Mercedes Martín-Martínez、Rosario Herranz、MaTeresa García-López、Ana Barber、Santiago Ballaz、Joaquín Del Río
DOI:10.1016/0960-894x(96)00160-6
日期:1996.4
A series of CCK-4 restricted analogues, incorporating a 3-oxoindolizidine bicyclic lactam as conformational constraint, is described. The 8-(Boc-tryptophyl)amino-2-benzyl derivatives behave as weak CCK-A or CCK-B receptor antagonists. The main factors for selectivity are the configuration at C-2 position of the 3-oxoindolizidine ring and at the Trp residue. Copyright (C) 1996 Elsevier Science Ltd